Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trialLudwig Kappos, Paul D. Crowe, Massimo Filippi et al.|Nature Medicine|2000Cited by 515
Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines.David H. Miller, Alan J. Thompson, Giuseppe Scotti et al.|Journal of Neurology Neurosurgery & Psychiatry|1991Cited by 371